Dylan Beynon

1.1K posts

Dylan Beynon banner
Dylan Beynon

Dylan Beynon

@dylanbeynon

3x Founder. CEO of Mindbloom, the #1 psychedelic therapy provider globally. 819,195+ sessions guided. Bending the curve of consciousness ⚡️

ATX | NYC | Edge City Katılım Haziran 2010
394 Takip Edilen1.2K Takipçiler
Sabitlenmiş Tweet
Dylan Beynon
Dylan Beynon@dylanbeynon·
After a lifetime of addiction, my mom died of a fentanyl overdose. A year later, my sister did, too. Then my dad hit rock bottom. He didn't shower, shave, or leave the house for a month and texted me suicidal thoughts like, “you know I love you and if anything happens to me it isn't your fault, right?" Ketamine therapy saved his life. In August 2021, my mom was found dead in an alley from a fentanyl overdose. But I lost her a long, long time ago. As far back as I can remember, my mom was consumed by severe mental illness and addiction. We tried everything: countless medications, therapy, multiple rehabilitation facilities, and even eastern medicines. Nothing worked. We were a working-class family in Anaheim, not-so-affectionately called Anacrime. The local addicts that my mom befriended and often brought into our home created an environment of violence, chaos, and fear. By age 12, I stopped speaking to my mom and tried to avoid her completely, often staying with friends until I knew my dad would be home. By age 16, it became so dangerous that we had no choice but to evict her from our home. She spent the rest of her life homeless and I never saw her alive again. Losing my mom could have been the end for me, too. I never met my biological father, and most kids in my position ended up in foster care, or worse. But I won the lottery. My stepfather, a mailman and bus driver, adopted me and did his best to build a house full of love under impossible conditions. Too many Americans are needlessly dying like my mom did. And the mental health crisis is only getting worse. In 2024: - Nearly 1 in 4 adults experienced mental illness - 2M people attempted suicide - Drug overdose deaths hit record highs - Less than half of adults with mental illness received treatment But lack of access isn’t the whole story. Traditional treatments like SSRIs and therapy are failing: - Response rates for depression are below 50%. - 4 in 5 patients relapse within five years. - The “chemical imbalance” theory behind SSRIs has been widely debunked. - Nearly 50% of people experience debilitating side effects—insomnia, weight gain, sexual dysfunction, and even suicidality—that often persist long after stopping treatment. Fortunately, we now have better tools. Psychedelic medicine is a 10X better mental health treatment. Decades of research show that these medicines work — but they haven’t been available to most Americans. Today, ketamine is the only psychedelic medicine that is legal to prescribe in the U.S. Over 100 studies show that ketamine is an effective, safe, and fast-acting mental health treatment, prompting many to call it the “biggest breakthrough in the field of depression in over 60 years.” In 2022, the Journal of Affective Disorders published the largest-ever peer-reviewed study of ketamine therapy, with real-world outcomes data from over Mindbloom 1,200 clients. The study showed that after only four treatment sessions: - 89% of clients experienced reductions in symptoms of depression or anxiety - 63% experienced clinically-significant reductions in symptoms - 30% achieved remission Remarkably, ketamine therapy also eliminated suicidal thoughts for nearly two-thirds of people who were experiencing them prior to treatment. And this is just the beginning. Decades of research by MAPS and other organizations have proven psychedelics are highly effective for conditions like PTSD and depression, especially for underserved groups like veterans. I’ve seen firsthand how psychedelic medicine can be the difference between life and death. One year after my mom overdosed, my sister died the exact same way—just three weeks after she was discharged from inpatient rehab. I had tried and failed to get her into treatment with ketamine or other psychedelics, and it hurt to know she never got to try medicines that could have saved her. After losing my mom and sister, my dad, my hero, sunk into a depression so deep that I was confident he wouldn’t make it out. - He didn’t leave home or bathe for nearly a month - He texted me a list of all his accounts and passwords “just in case something happens to me” - He texted me not to throw everything away in the condo when he’s gone because he has silver hidden inside it - He refused to let me come see him or accept any help from me - He texted me “you know I love you and anything that happens to me isn’t your fault, right?” It was clear that he was preparing to end his life. My dad had resisted ketamine therapy for years, scared by the same stigma that prevents so many people from getting the help they need. Fortunately, rock bottom was the catalyst I needed to convince him to try at-home ketamine therapy through Mindbloom. Working directly with Mindbloom’s Medical Director and my friend, Dr. Leonardo Vando, to whom I will be forever grateful, my dad invested in his healing. The results were incredible: - He worked through his grief and found his will to keep going - He started exercising regularly for the first time in his life and lost 50 pounds - He reintegrated into his friend group and built his support network back up - He became open to finding a partner for the third act of his life, got engaged, and became a father to three new stepchildren—I officiated the wedding last summer. - He reached a place of happiness, vitality, and optimism I never in a million years thought I’d see him have again Psychedelic medicine saved my dad’s life, and it can help the millions of Americans who are still suffering. The tools we need to fix the mental health epidemic are right in front of us we just have to use them.
Dylan Beynon tweet mediaDylan Beynon tweet media
English
49
47
582
92.4K
Dylan Beynon
Dylan Beynon@dylanbeynon·
@IterIntellectus Girls = more likely to stay close to fam and carry your mission's torch. Boys = more likely to strike out on own and make an out-sized impact Maxxing for enjoying kids, girl. Maxxing for impact, boy. Answer: 1+ each and 3+ total to fulfill duty to replace ourselves.
English
0
0
7
699
vittorio
vittorio@IterIntellectus·
this is what happens when you live in a matriarchy and women have much more privilege then men
vittorio tweet media
English
140
274
4.4K
61K
Dylan Beynon retweetledi
Chrys Bader
Chrys Bader@chrysb·
let me add some important nuance here so people don’t take away the wrong message: 1. rumination and introspection are two very different things 2. rumination = looping the same thoughts without progress → more distress 3. introspection = examining your experiences and beliefs to unlock insight, alignment, and forward movement maybe the reason this is getting confused is because without new insight, a reframe, or a decision, introspection can quietly slip into rumination rule of thumb: - rumination = motion without progress - introspection = reflection that leads to change
The All-In Podcast@theallinpod

“Rumination is the path to unhappiness.” - J Cal “Nobody gives a sh*t about your feelings.” “It's only going to make you miserable.” “Just do what I've been doing for 30 years: Retardmaxxing.” “All you have to do is work. Start new projects, 9 out of 10 fail. One wins, and you're golden. Go sit courtside at the Knicks game.” “Keep going. Just keep moving forward. Don't write anything down.”

English
17
28
308
69.7K
Dylan Beynon
Dylan Beynon@dylanbeynon·
I’m hiring Mindbloom’s 3rd PSYCHEDELIC LAWYER. Our 1st Psychedelic Lawyer @mikeroplastics graduated to founding his 1st venture-backed startup Proxima Health. I wrote the 2nd check in. Ca-ching. Our 2nd Psychedelic Lawyer Dean L'hospital is an AI-first builder lawyer, artist, and former founder. I promoted him to General Counsel, and we’re doubling down on our core competency innovating and winning offensively and defensively in regulatory. We’re the largest provider of ketamine therapy in the world with over 800,000 sessions facilitated across 38 states, hundreds of millions of dollars in psychedelic therapy sold, profitable, and still just getting started. As Psychedelic Lawyer / Legal Counsel, you’ll help a massive number of Americans and help them a lot (life-changing is the most common testimonial we get) while working on big-time initiatives, including literally changing and shaping psychedelic medicine law. Examples of things we’ve done and are doing: + Launched 1st national brand for psychedelic therapy, at-home psychedelic therapy, and then at-home injectable psychedelic therapy. + Suing the WSJ for lying we killed Matthew Perry for $88M (just won the motion to dismiss so big WSJ fired their litigators). + Led mental health industry-wide lobbying that solidified telemedicine prescribing for controlled substances after COVID for everyone. + Consistently publish the largest peer-reviewed clinical studies and white papers in psychedelic medicine history. + Building a truly AI-First legal, regulatory, and compliance machine to support in-house counsel and our 30+ outside lawyers, lobbyists, insurers, compliance folks, etc. + Work with a founding CEO who gets and prioritizes legal and regulatory (under-valued) — I last co-founded Mighty and Justice Bolt, the leading software + capital provider to personal injury lawyers (and doctors and funders) spanning legaltech, fintech, a hedge fund, a law firm, and one of the first AI companies in legal back when we still called it Machine Learning. I'm prioritizing signs of exceptional ability and achievement, especially in creative problem-solving intelligence, lifelong learning, obsession with our mission, and obsession with AI. Healthcare law experience a bonus but not required. If you know a lawyer at any seniority and think “they’re a Psychedelic Lawyer,” forwarding this to them could literally change and save lives <3 Link to job below.
English
2
2
15
2.4K
Dylan Beynon retweetledi
Paul F. Austin
Paul F. Austin@PaulAustin3w·
It’s highly likely that we could see two psychedelic drugs approved for three indications by end of this year: - Psilocybin for TRD (Compass) - Psilocybin for MDD (Usona) - Methylone for PTSD (Otsuka via Transcend) What does this mean for the future of mental health?
English
17
14
110
7.6K
Christian Angermayer
Christian Angermayer@C_Angermayer·
Today’s Presidential Executive Order on #psychedelics marks a major milestone in the history of these valuable substances. It corrects a fundamental mistake made in 1970, when President Nixon established the Controlled Substances Act (CSA) and classified psychedelics as Schedule I substances - a designation that had no basis. For largely political reasons, these highly promising compounds were pushed out of the medical realm and into illegality. Now, they are coming back - with force. The executive order is directing the Food and Drug Administration (FDA), the Drug Enforcement Administration (DEA), the Department of Justice and other federal agencies to reduce the red tape and restrictions that have long stymied researchers and biotech companies in the field. As a result, I expect drug approval processes to accelerate and become less costly. I am very proud that @ataibeckley is at the forefront of this field, with one of the broadest pipelines in psychedelics, including clinical programs focused on DMT, 5-MeO-DMT, R-MDMA and – as previously disclosed - ibogaine and additional novel, discovery compounds in various stages of preclinical development. Since I founded AtaiBeckley in 2017, and seed-funded @COMPASSPathway that same year, these two companies have raised more than $1.5 billion to advance clinical research and development of psychedelic therapies. As access to capital was limited early on - since most investors dismissed the idea as crazy - I invested over $100 million of my own capital and have never sold a single $ATAI share (nor do I intend to). The public sentiment around psychedelics as FDA-regulated drugs has gone from “this is a crazy idea that will ruin your career” to being on the verge of what the market anticipates will be the first regulatory approval of a psychedelic with COMP360… all in less than a decade. What a journey. But we are still only at the beginning. I strongly believe the world will benefit from the full spectrum of psychedelic compounds that demonstrate medical and commercial value. I also believe that delivery mechanisms and treatment duration are critical, as these therapies must fit within the commercial realities and infrastructure of the U.S. and global healthcare systems. That conviction is exactly why AtaiBeckley has built such a broad and diversified pipeline with a focus on short-acting psychedelics: x.com/C_Angermayer/s… Once approved, I expect physicians will determine which treatments are best suited to specific patient profiles. Over time, better data and real-world evidence will significantly improve this matching - delivering the right FDA-approved treatment to the right patient. This level of presidential attention also reinforces another long-held belief of mine: the support – and potential use - for psychedelic therapies is far larger and broader than most people have historically assumed. Take once more AtaiBeckley as an example. Most analysts currently model compounds like BPL-003 and VLS-01 primarily within treatment-resistant depression (TRD) - patients who have already failed at least two antidepressant treatments. But my own personal view (and ultimate vision) would be to progress to these treatments sooner, especially when existing treatments often have limited efficacy and significant side effects. Given the favorable safety profiles and promising efficacy of psychedelics we are seeing in the clinical trials run to date, and based on my own extensive discussions with therapists who have worked with these compounds, I personally believe psychedelic therapies have the potential to become first-line treatments - and, over time, even potentially play a role in prevention. Thank you, @realDonaldTrump, for today’s important signal of support, and @joerogan for driving it! Most importantly, thank you to everyone working behind the scenes to make this possible today - and to the fellow drug developers advancing these therapies. This has been, and will continue to be, a truly collaborative effort. You can all be proud of the meaningful difference you are about to make for the millions of patients in need.
Christian Angermayer tweet media
English
61
111
741
372.9K
Dylan Beynon
Dylan Beynon@dylanbeynon·
@AJA_Cortes City of the future. Moved to ATX 5 years ago after 10 in NYC to build Edge Village, a live-next-to-friends community. So hard to leave, I literally mourned. ATX exceeds high expectations. It has gravity. It has velocity. It has heart. You can feel the acceleration.
English
0
0
2
758
The Kobeissi Letter
The Kobeissi Letter@KobeissiLetter·
BREAKING: President Trump appoints JD Vance as the “Fraud Czar.”
The Kobeissi Letter tweet media
English
416
380
3.6K
349.1K
Dylan Beynon
Dylan Beynon@dylanbeynon·
The Gell-Bott Amnesia Effect 1. Read thing from AI you're an amateur in and think "wow so smart and true." 2. Read something from AI you're an expert in and think "wow so retarded and wrong." 3. Read something else from AI you're an amateur in and forget it lost credibility.
English
0
0
2
207
Dylan Beynon
Dylan Beynon@dylanbeynon·
I get emails from investment bankers nearly every day. Mindbloom is my life's work. You don't sell away your life's work. Ever. Also growing up, my favorite ways to have fun were video games and sex. And building Mindbloom is way more fun than video games.
Sean Frank@Seanfrank

We own all of Ridge. me + 5 guys. At any point, we can cash out and sell for life changing money. there is ALWAYS a market for EBITDA positive, growing brands. not having investors means the deal is clean- no preference, no board member vetos. I keep running ridge because it is fun and I like it. Build a business YOU LIKE to run. Not one you are trapped in. This is the number one reason to not raise money.

English
0
0
2
410
Dylan Beynon
Dylan Beynon@dylanbeynon·
@Josh__Hardman Do you believe this chart you posted to be remotely true and if so, why?
English
0
0
0
208
Dylan Beynon
Dylan Beynon@dylanbeynon·
@C_Angermayer Increasingly bullish on criticality of shorter duration psychedelics for affordably and accessibly fitting into US healthcare systems for patients, providers, and payers 🎯
English
0
0
3
99
Christian Angermayer
Christian Angermayer@C_Angermayer·
At present, investors and analysts appear to be approaching the psychedelic sector largely as a single thematic trade, without fully differentiating between companies and their respective strengths and weaknesses. In my view, $ATAI is best positioned across key dimensions: intellectual property, method of delivery, and treatment duration. Duration is critical. I struggle to see a scalable commercial future for treatments lasting more than six hours; the shorter the treatment, the more viable it becomes from both a patient and payer perspective IMO. @ataibeckley's BPL-003, with a total treatment time of approximately two hours from start to finish, stands out in this regard, offering a significantly more practical and scalable solution.
Christian Angermayer tweet media
Christian Angermayer@C_Angermayer

x.com/i/article/2024…

English
5
4
57
5.1K
signüll
signüll@signulll·
i know everyone is building ai software but is there anyone opening up an ai native law firm? like built from the ground up, every service, every area is a person or two empowered by custom built software.
English
83
1
199
34K
Dylan Beynon
Dylan Beynon@dylanbeynon·
When democracy dotcom acquired my first startup, Voter's Friend, I hoped what we built would echo on into eternity transforming local elections. TIL it's helping @mcuban increase his domain authority. Better than nothing.
TBPN@tbpn

After buying broadcast dotcom for $8,000 in 1997, @mcuban went on a domain name buying spree when he realized he could use simple URLs to route traffic to the site. As a result, he says he now owns democracy dotcom, baseball dotcom, mrpresident dotcom, sandwich dotcom, finalfour dotcom, and more. "You name it, I've bought it."

English
0
0
0
234